Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine + ECT in Treatment Resistant Depression
NCT02522377Phase 2Completed
- Sponsor
- Cleveland Clinic
- Start
- Aug 2015
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ketamine in major depressive disorder (MDD), sponsored by Cleveland Clinic. Started Aug 2015; status: completed.
02
Drugs
ketamine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02522377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02522377.